Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021   48,627,739      
Beginning Balance at Dec. 31, 2021 $ 85,004 $ 5 $ 198,179 $ (112,811) $ (369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Legacy Shapeways common stock upon exercise of stock options (in shares)   217,967      
Issuance of Legacy Shapeways common stock upon exercise of stock options 99   99    
Stock-based compensation expense 312   312    
Net loss (4,037)     (4,037)  
Transfer of Private Warrants to Public Warrants 382   382    
Foreign currency translation adjustment (52)       (52)
Ending Balance at Mar. 31, 2022 $ 81,708 $ 5 198,972 (116,848) (421)
Common Stock, Ending Balance (in shares) at Mar. 31, 2022   48,845,706      
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022 49,445,174 49,445,174      
Beginning Balance at Dec. 31, 2022 $ 67,791 $ 5 201,362 (133,032) (544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Legacy Shapeways common stock upon exercise of stock options (in shares) 250 164,052      
Cancellation of restricted stock (in shares)   (59)      
Stock-based compensation expense $ 805   805    
Net loss (7,403)     (7,403)  
Foreign currency translation adjustment 39       39
Ending Balance at Mar. 31, 2023 $ 61,232 $ 5 $ 202,167 $ (140,435) $ (505)
Common Stock, Ending Balance (in shares) at Mar. 31, 2023 49,609,167 49,609,167